The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
Open accessAbstract
We have performed a systematic review and meta-analysis of proliferation markers (Ki-67, mitotic index (MI), proliferating cell nuclear antigen (PCNA) and thymidine or bromodeoxyuridine labelling index (LI)) with respect to survival in early breast cancer. Eighty-five studies involving 32,825 patients were analysed. Ki-67 (43 studies, 15,790 patients), MI (20 studies, 7021 patients), and LI (11 studies, 7337 patients) were associated with significantly shorter overall and disease free survival, using results from univariate and multivariate analyses from the individual studies. PCNA (11 studies, 2677 patients) was associated with shorter overall survival by multivariate analysis only, because of lack of data. There was some evidence for publication bias, but all markers remained significant after allowing for this. Ki-67, MI, PCNA and LI are associated with worse survival outcomes in early breast cancer. However, whether these proliferation markers provide additional prognostic information to commonly used prognostic indices remains unclear.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Pathological prognostic factors in breast cancer
Elston, C. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00034-7 · Cited by 1,735
The Nottingham prognostic index in primary breast cancer
Galea, M. H., Blamey, R. W., Elston, C. E., & Ellis, I. O. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01840834 · Cited by 1,070
Ravdin, P. M., Siminoff, L. A., Davis, G. J., Mercer, M. B., Hewlett, J., Gerson, N., & Parker, H. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.980 · Cited by 996
de Azambuja, E., Cardoso, F., de Castro, G., Colozza, M., Mano, M. S., Durbecq, V, Sotiriou, C., Larsimont, D., Piccart-Gebhart, M. J., & Paesmans, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603756 · Cited by 959
Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?
Brenton, J. D., Carey, L. A., Ahmed, A. A., & Caldas, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3845 · Cited by 953
Self-citationProliferation Marker Ki-67 in Early Breast Cancer
Urruticoechea, A., Smith, I. E., & Dowsett, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.501 · Cited by 837
A prognostic index in primary breast cancer
Haybittle, J. L., Blamey, R. W., Elston, C. W., Johnson, J., Doyle, P. J., Campbell, F. C., Nicholson, R. I., & Griffiths, K. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.62 · Cited by 699
Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer
Olivotto, I. A., Bajdik, C. D., Ravdin, P. M., Speers, C. H., Coldman, A. J., Norris, B. D., Davis, G. J., Chia, S. K., & Gelmon, K. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.178 · Cited by 567
Teschendorff, A. E., Miremadi, A., Pinder, S. E., Ellis, I. O., & Caldas, C. (2007) · Genome Biology · doi:10.1186/gb-2007-8-8-r157 · Cited by 497
Self-citationSotiriou, C., & Piccart, M. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2173 · Cited by 461
Prognostic value of proliferation in invasive breast cancer: a review: Table 1
van Diest, P. J., van der Wall, E., & Baak, J. P. A. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.010777 · Cited by 385
A gene-expression signature to predict survival in breast cancer across independent data sets
Naderi, A., Teschendorff, A. E., Barbosa-Morais, N. L., Pinder, S. E., Green, A. R., Powe, D. G., Robertson, J. F. R., Aparicio, S., Ellis, I. O., Brenton, J. D., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1209920 · Cited by 256
Self-citationPrognostic molecular markers in early breast cancer
Esteva, F. J., & Hortobagyi, G. N. (2004) · Breast Cancer Research · doi:10.1186/bcr777 · Cited by 247
Mirza, A. N., Mirza, N. Q., Vlastos, G., & Singletary, S. E. (2002) · Annals of Surgery · doi:10.1097/00000658-200201000-00003 · Cited by 246
Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index
Callagy, G. M., Pharoah, P. D., Pinder, S. E., Hsu, F. D., Nielsen, T. O., Ragaz, J., Ellis, I. O., Huntsman, D., & Caldas, C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2719 · Cited by 237
Self-citationJoensuu, H., Isola, J. J., Lundin, M., Salminen, T. M., Holli, K., Kataja, V. V., Pylkkänen, L. H., Turpeenniemi-Hujanen, T. M., von Smitten, K., & Lundin, J. E. (2003) · PubMed · Cited by 207
Trihia, H., Murray, S., Price, K., Gelber, R. D., Golouh, R., Goldhirsch, A., Coates, A. S., Collins, J., Castiglione‐Gertsch, M., & Gusterson, B. A. (2003) · Cancer · doi:10.1002/cncr.11188 · Cited by 189
Keshgegian, A. A., & Cnaan, A. (1995) · American Journal of Clinical Pathology · doi:10.1093/ajcp/104.1.42 · Cited by 184
Pinder, S., Wencyk, P., Sibbering, D., Bell, J., Elston, C., Nicholson, R., Robertson, J., Blamey, R., & Ellis, I. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.30 · Cited by 179
Self-citationClahsen, P. C., van de Velde, C. J., Duval, C., Pallud, C., Mandard, A. M., Delobelle-Deroide, A., van den Broek, L., Sahmoud, T. M., & van de Vijver, M. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.470 · Cited by 171
Jalava, P., Kuopio, T., Juntti‐Patinen, L., Kotkansalo, T., Kronqvist, P., & Collan, Y. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02402.x · Cited by 169
Minichromosome Maintenance Protein 2 Is a Strong Independent Prognostic Marker in Breast Cancer
Gonzalez, M. A., Pinder, S. E., Callagy, G., Vowler, S. L., Morris, L. S., Bird, K., Bell, J. A., Laskey, R. A., & Coleman, N. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.121 · Cited by 158
Self-citationYamashita, H., Nishio, M., Toyama, T., Sugiura, H., Zhang, Z., Kobayashi, S., & Iwase, H. (2003) · Breast Cancer Research · doi:10.1186/bcr738 · Cited by 152
Lee, A. H. S., Pinder, S. E., Macmillan, R. D., Mitchell, M., Ellis, I. O., Elston, C. W., & Blamey, R. W. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.10.021 · Cited by 137
Self-citationThor, A. D., Liu, S., Moore, D. H., & Edgerton, S. M. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.470 · Cited by 137
Liu, S., Edgerton, S. M., Moore, D. H., & Thor, A. D. (2001) · PubMed · Cited by 122
Applying the Nottingham Prognostic Index to a Swedish breast cancer population
Sundquist, M., Thorstenson, S., Brudin, L. H., & Nordenskjöld, B. A. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006052115874 · Cited by 118
de Jong, Diest, V., & van Baak, A. A. (2000) · Histopathology · doi:10.1046/j.1365-2559.2000.00850.x · Cited by 115
Jensen, V., Ladekarl, M. B., Holm‐Nielsen, P., Melsen, F., & Sørensen, F. B. (1995) · The Journal of Pathology · doi:10.1002/path.1711760405 · Cited by 112
Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer.
Brown, R. W., Allred, C., Clark, G. M., Osborne, C. K., & Hilsenbeck, S. G. (1996) · PubMed · Cited by 109
MIB-1 labelling index is an independent prognostic marker in primary breast cancer
Jansen, R. L. H., Hupperets, P. S. G. J., Arends, J. W., Joosten-Achjanie, S., Volovics, A., Schouten, H. C., & Hillen, H. F. P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.515 · Cited by 106
Seshadri, R., Leong, A. S. ‐., McCaul, K. A., Firgaira, F. A., Setlur, V., & Horsfall, D. J. (1996) · International Journal of Cancer · Cited by 90
Clahsen, P. C., de Velde, C. J. H. V., Duval, C., Pallud, C., Mandard, A. M., Delobelle-Deroïde, A., van den Broek, L., & van de Vijver, M. J. (1999) · European Journal of Surgical Oncology · doi:10.1053/ejso.1999.0657 · Cited by 90
A consensus prognostic gene expression classifier for ER positive breast cancer
Teschendorff, A. E., Naderi, A., Barbosa‐Morais, N. L., Pinder, S. E., Ellis, I. O., Aparicio, S. A. J. R., Brenton, J. D., & Caldas, C. (2006) · Genome biology · doi:10.1186/gb-2006-7-10-r101 · Cited by 87
Self-citationRudolph, P., Kühling, H., Alm, P., Fernö, M., Baldetorp, B., Olsson, H. L., & Parwaresch, R. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11132 · Cited by 77
Immunologic Proliferation Marker Ki-S2 as Prognostic Indicator for Lymph Node-Negative Breast Cancer
Rudolph, P., Alm, P., Heidebrecht, H. J., Bolte, H., Ratjen, V., Baldetorp, B., Fernö, M., Olsson, H. L., & Parwaresch, R. M. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.3.271 · Cited by 73
Haerslev, T., Jacobsen, G. K., & Zedeler, K. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806492 · Cited by 70
Jannink, I., van Diest, P. J., & Baak, J. P. A. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90270-8 · Cited by 68
Domagała, W., Markiewski, M. M., Harezga, B., Dukowicz, A., & Osborn, M. (1996) · PubMed · Cited by 68
Reading the prognosis of the individual with breast cancer
Blamey, R. W., Pinder, S. E., Ball, G., Ellis, I. O., Elston, C. W., Mitchell, M. J., & Haybittle, J. L. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.01.003 · Cited by 57
Self-citationIacopetta, B. J., Grieu, F., Powell, B. L., et al. (1998) · PubMed · Cited by 53
The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67
Goodson, W. H., Moore, D. H., Ljung, B., Chew, K., Mayall, B. H., Smith, H. S., & Waldman, F. M. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006344010050 · Cited by 47
Perera, S. M., Thomas, J. A., Burke, M. M., & Crawford, D. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199802)184:2<130::aid-path19>3.0.co;2-w · Cited by 45
Bukholm, I., Bukholm, G., Holm, R., et al. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.5.368 · Cited by 39
A simple index using video image analysis to predict disease outcome in primary breast cancer
Lockwood, C. A., Ricciardelli, C., Raymond, W. A., Seshadri, R., McCaul, K. A., & Horsfall, D. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990621)84:3<203::aid-ijc1>3.0.co;2-u · Cited by 32
The prognostic relevance of estimates of proliferative activity in early breast cancer
Offersen, B. V., Sørensen, F. B., Knoop, A. S., & Overgaard, J. (2003) · Histopathology · doi:10.1111/j.1365-2559.2003.01745.x · Cited by 31
Weikel, W., Brumm, C., Wilkens, C., Beck, T., & Knapstein, P. G. (1995) · PubMed · Cited by 20
Bevilacqua, P., Verderio, P., Barbareschi, M., Bonoldi, E., Boracchi, P., Palma, P. D., & Gasparini, G. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806494 · Cited by 19
Breast cancer metastatic phenotype as predicted by histologic tumor markers.
Heimann, R., Ferguson, D. J. P., Recant, W. M., et al. (1997) · PubMed · Cited by 18
Cited by
Systematic reviews: CRD's guidance for undertaking reviews in health care
Tacconelli, E. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70065-7 · Cited by 3,245
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Cheang, M. C. U., Chia, S. K., Voduc, D., Gao, D., Leung, S., Snider, J., Watson, M., Davies, S., Bernard, P. S., Parker, J. S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp082 · Cited by 2,249
Dowsett, M., Nielsen, T. O., A'Hern, R., Bartlett, J., Coombes, R. C., Cuzick, J., Ellis, M., Henry, N. L., Hugh, J. C., Lively, T., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr393 · Cited by 1,977
Ki67 in breast cancer: prognostic and predictive potential
Yerushalmi, R., Woods, R., Ravdin, P. M., Hayes, M. M., & Gelmon, K. A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70262-1 · Cited by 1,207
Inwald, E. C., Klinkhammer-Schalke, M., Hofstädter, F., Zeman, F., Koller, M., Gerstenhauer, M., & Ortmann, O. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2560-8 · Cited by 601
Metadata
- Authors
- Stuart-Harris, R., Caldas, C., Pinder, S. E., & Pharoah, P.
- Venue
- The Breast
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 17
- Issue
- 4
- Pages
- 323-334
- ISSN
- 0960-9776 (ISSN-L)
- OpenAlex
- W2040872996
- Cited by
- 431
- References
- 54
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.